Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
The manufacturer absorbs the difference to make their premium medication accessible and drive market share
Product Format & Classification This compound is offered in a research format intended for educational and laboratory contexts
Lindeman, Calvin A
Fatigue is occasionally reported, especially in early weeks
GLP-1s reduce appetite, making it harder to meet nutritional needsmonitoring essential vitamins, minerals, and protein ensures proper fueling
US$ 20.61
US$ 24.64
US$ 23.98
US$ 26.75
